Researchers from Harvard and MIT have succeeded in transplanting insulin-producing cells into mice with the equivalent of type 1 diabetes. In 2014, the same research team mass produced the glucose-responsive, insulin-producing beta cells from human embryonic (SC-β) stem cells. The treated mice appeared to by disease-free, without producing any adverse immune responses, for as long as 6 months after receiving the transplanted cells. If the therapy were to work similarly in humans, this would translate into several years of injection-free diabetes control.
According to a co-author of the study, Daniel Anderson, this development “has the potential to provide diabetics with a new pancreas that is protected from the immune system, which would allow them to control their blood sugar without taking drugs.” (via Gizmodo)